LyphoMed Inc said it intends tofile a registration statement with the Securities and ExchangeCommission covering the sale of 70 mln dlrs principal amount ofconvertible subordinated debentures.    Concurrent with the debenture offering, LyphoMed said itplans to sell an additional 30 mln dlrs of debentures inFujisawa Pharmaceutical Co Ltd, which currently owns about 30pct of the company's common stock.    It said the offering will be made only by prospectus. Reuter&#3;